CN116368156A - 基于从头设计的蛋白开关的模块化和通用化生物传感器平台 - Google Patents
基于从头设计的蛋白开关的模块化和通用化生物传感器平台 Download PDFInfo
- Publication number
- CN116368156A CN116368156A CN202180049976.6A CN202180049976A CN116368156A CN 116368156 A CN116368156 A CN 116368156A CN 202180049976 A CN202180049976 A CN 202180049976A CN 116368156 A CN116368156 A CN 116368156A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- seq
- reporter
- acid sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030836P | 2020-05-27 | 2020-05-27 | |
| US63/030,836 | 2020-05-27 | ||
| US202063051549P | 2020-07-14 | 2020-07-14 | |
| US63/051,549 | 2020-07-14 | ||
| US202063067643P | 2020-08-19 | 2020-08-19 | |
| US63/067,643 | 2020-08-19 | ||
| PCT/US2021/034104 WO2021242780A2 (en) | 2020-05-27 | 2021-05-25 | Modular and generalizable biosensor platform based on de novo designed protein switches |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116368156A true CN116368156A (zh) | 2023-06-30 |
Family
ID=76829627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180049976.6A Pending CN116368156A (zh) | 2020-05-27 | 2021-05-25 | 基于从头设计的蛋白开关的模块化和通用化生物传感器平台 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230279056A1 (https=) |
| EP (1) | EP4157854A2 (https=) |
| JP (1) | JP2023527786A (https=) |
| KR (1) | KR20230017215A (https=) |
| CN (1) | CN116368156A (https=) |
| AU (1) | AU2021282172A1 (https=) |
| CA (1) | CA3178016A1 (https=) |
| IL (1) | IL298192A (https=) |
| MX (1) | MX2022014917A (https=) |
| WO (1) | WO2021242780A2 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121049494A (zh) * | 2025-08-27 | 2025-12-02 | 南昌大学 | 用于检测伏马毒素B1的dlucCage生物传感器及其制备方法和应用 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4182027A1 (en) * | 2020-07-14 | 2023-05-24 | University of Washington | Sars-cov-2 inhibitors |
| US20240309059A1 (en) * | 2021-07-07 | 2024-09-19 | National University Corporation Tokyo Medical And Dental University | Peptide having anti-viral activity, anti-viral agent comprising said peptide, and method for producing said anti-viral agent |
| TW202419461A (zh) * | 2022-11-01 | 2024-05-16 | 華盛頓大學 | 全新設計的螢光素酶 |
| WO2024102823A2 (en) * | 2022-11-09 | 2024-05-16 | The Regents Of The University Of California | Systems and methods for detecting and/or screening protein aggregation and/or disaggregation |
| IT202200025416A1 (it) * | 2022-12-13 | 2024-06-13 | Univ Pisa | Biosensore per la rilevazione di particelle virali |
| WO2025101453A1 (en) * | 2023-11-07 | 2025-05-15 | University Of Washington | De novo design of potent minibinder antagonists of il-6r, gp130, and il1-r1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015067302A1 (en) * | 2013-11-05 | 2015-05-14 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sensor molecules and uses thereof |
| WO2019241438A2 (en) * | 2018-06-12 | 2019-12-19 | Promega Corporation | Multipartite luciferase |
| CA3106279A1 (en) | 2018-07-19 | 2020-01-23 | University Of Washington | De novo design of protein switches |
-
2021
- 2021-05-25 KR KR1020227042798A patent/KR20230017215A/ko active Pending
- 2021-05-25 MX MX2022014917A patent/MX2022014917A/es unknown
- 2021-05-25 US US17/999,524 patent/US20230279056A1/en active Pending
- 2021-05-25 CA CA3178016A patent/CA3178016A1/en active Pending
- 2021-05-25 EP EP21739477.4A patent/EP4157854A2/en not_active Withdrawn
- 2021-05-25 AU AU2021282172A patent/AU2021282172A1/en not_active Abandoned
- 2021-05-25 CN CN202180049976.6A patent/CN116368156A/zh active Pending
- 2021-05-25 WO PCT/US2021/034104 patent/WO2021242780A2/en not_active Ceased
- 2021-05-25 JP JP2022572292A patent/JP2023527786A/ja not_active Withdrawn
- 2021-05-25 IL IL298192A patent/IL298192A/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121049494A (zh) * | 2025-08-27 | 2025-12-02 | 南昌大学 | 用于检测伏马毒素B1的dlucCage生物传感器及其制备方法和应用 |
| CN121049494B (zh) * | 2025-08-27 | 2026-02-27 | 南昌大学 | 用于检测伏马毒素B1的dlucCage生物传感器及其制备方法和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023527786A (ja) | 2023-06-30 |
| US20230279056A1 (en) | 2023-09-07 |
| CA3178016A1 (en) | 2021-12-02 |
| AU2021282172A1 (en) | 2022-12-15 |
| WO2021242780A3 (en) | 2022-02-17 |
| IL298192A (en) | 2023-01-01 |
| MX2022014917A (es) | 2023-02-22 |
| KR20230017215A (ko) | 2023-02-03 |
| EP4157854A2 (en) | 2023-04-05 |
| WO2021242780A2 (en) | 2021-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116368156A (zh) | 基于从头设计的蛋白开关的模块化和通用化生物传感器平台 | |
| Quijano-Rubio et al. | De novo design of modular and tunable protein biosensors | |
| Pacesa et al. | One-shot design of functional protein binders with BindCraft | |
| Pacesa et al. | BindCraft: one-shot design of functional protein binders | |
| US20230176057A1 (en) | Detection assay for sars-cov-2 virus | |
| Zahradnik et al. | A protein-engineered, enhanced yeast display platform for rapid evolution of challenging targets | |
| Rizk et al. | Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins | |
| US20220025003A1 (en) | Reagents and methods for controlling protein function and interaction | |
| EP2663642B1 (en) | Treponema pallidum triplet antigen | |
| Huber et al. | In vitro selection and characterization of DARPins and Fab fragments for the co-crystallization of membrane proteins: The Na+-citrate symporter CitS as an example | |
| JP2019205450A (ja) | 植物シスタチンに由来する足場タンパク質 | |
| WO2014071978A1 (en) | Nucleic acids encoding chimeric polypeptides for library screening | |
| CN112694535B (zh) | 用于抗体检测的多功能蛋白分子开关 | |
| Díaz-Perlas et al. | High-affinity peptides developed against calprotectin and their application as synthetic ligands in diagnostic assays | |
| Lu et al. | A multivalent and thermostable nanobody neutralizing SARS-CoV-2 omicron (B. 1.1. 529) | |
| CN118139895A (zh) | 基于发光的抗原测定法 | |
| Stains et al. | A general approach for receptor and antibody-targeted detection of native proteins utilizing split-luciferase reassembly | |
| Quijano-Rubio et al. | De novo design of modular and tunable allosteric biosensors | |
| Yasui et al. | A sweet protein monellin as a non-antibody scaffold for synthetic binding proteins | |
| Slezak et al. | Engineered protein G variants for multifunctional antibody‐based assemblies | |
| CN106939034B (zh) | 用于鉴定受试者所感染的hev基因型的方法和试剂盒 | |
| Miyafusa et al. | Local disorder of the C-terminal segment of the heavy chain as a common sign of stressed antibodies evidenced with a peptide affinity probe specific to non-native IgG | |
| Piotukh et al. | A novel hSH3 domain scaffold engineered to bind folded domains in CD2BP2 and HIV capsid protein | |
| Slezak et al. | Engineered Protein-G variants for plug-and-play applications | |
| Little | The Type IV pilus secretin BfpB: structural analysis and binding interactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |